Proteolytic processing of nuclear factor kappa B by calpain in vitro

FEBS Lett. 1996 Apr 29;385(1-2):109-13. doi: 10.1016/0014-5793(96)00360-2.

Abstract

Nuclear factor kappaB (NF-kappaB) is a transcription factor that is critical for the inducible expression of multiple cellular and viral genes. Using the electrophoretic mobility shift assay, we demonstrated that DNA binding activity of NF-kappaB was abolished by proteolysis with mu- and m-calpains in vitro. The proteolysis of NF-kappaB by calpains and hence the abolition of its DNA binding was prevented by calpastatin, calpain inhibitor I and proteasome inhibitor. We also provided evidence that calpains degrade the C-terminal domain of NF-kappaB by Western blot using anti-NF-kappaB (p65) C-terminal antibody. These observations indicate that calpains regulate gene expression through processing of NF-kappaB.

MeSH terms

  • Base Sequence
  • Calcium-Binding Proteins / pharmacology
  • Calpain / antagonists & inhibitors
  • Calpain / metabolism*
  • Cysteine Proteinase Inhibitors / pharmacology
  • DNA / metabolism
  • Glycoproteins / pharmacology
  • Humans
  • Leupeptins / pharmacology
  • Molecular Sequence Data
  • NF-kappa B / isolation & purification
  • NF-kappa B / metabolism*
  • Protein Processing, Post-Translational*

Substances

  • Calcium-Binding Proteins
  • Cysteine Proteinase Inhibitors
  • Glycoproteins
  • Leupeptins
  • NF-kappa B
  • calpain inhibitors
  • carbobenzoxy-leucyl-leucyl-norvalinal
  • calpastatin
  • DNA
  • Calpain